Rover Diagnostics
Neil Geoghagen possesses a strong background in laboratory management and scientific research, holding positions such as Laboratory Manager at Rover Diagnostics and Senior Scientist at Exarta Therapeutics. Previous roles include Scientist in Cell Biology at Alphina Therapeutics, Consultant at Sterling Suns, and Scientist at Boehringer Ingelheim. Neil's academic credentials include a Master of Science in Biochemical Pharmacology from the University at Buffalo and a Bachelor of Applied Science in Biochemistry from the University of Maryland.
This person is not in any teams
Rover Diagnostics
Rover Diagnostics was founded in 2018 by Samuel Sia and Mark Fasciano in collaboration with Columbia University. Based in New York City, Rover’s primary mission is to help meet the urgent global need for a cost-effective, highly sensitive, mass-produced point-of-care COVID-19 instrument and test kit system. Rover is a participant in the NIH RADx program to accelerate availability and capacity for COVID testing.